PT Suparma Tbk Statistics

Total Valuation

PT Suparma Tbk has a market cap or net worth of IDR 807.45 billion. The enterprise value is 1.23 trillion.

Market Cap	807.45B
Enterprise Value	1.23T

Important Dates

The next estimated earnings date is Monday, July 28, 2025.

Earnings Date	Jul 28, 2025
Ex-Dividend Date	n/a

Share Statistics

PT Suparma Tbk has 3.15 billion shares outstanding.

Current Share Class	3.15B
Shares Outstanding	3.15B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	81.63%
Owned by Institutions (%)	0.02%
Float	n/a

Valuation Ratios

The trailing PE ratio is 8.46.

PE Ratio	8.46
Forward PE	n/a
PS Ratio	0.30
PB Ratio	0.34
P/TBV Ratio	0.34
P/FCF Ratio	1.30
P/OCF Ratio	1.23
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.23, with an EV/FCF ratio of 1.99.

EV / Earnings	12.94
EV / Sales	0.46
EV / EBITDA	4.23
EV / EBIT	7.03
EV / FCF	1.99

Financial Position

The company has a current ratio of 2.81, with a Debt / Equity ratio of 0.24.

Current Ratio	2.81
Quick Ratio	0.76
Debt / Equity	0.24
Debt / EBITDA	1.99
Debt / FCF	0.94
Interest Coverage	4.81

Financial Efficiency

Return on equity (ROE) is 4.03% and return on invested capital (ROIC) is 3.76%.

Return on Equity (ROE)	4.03%
Return on Assets (ROA)	3.30%
Return on Invested Capital (ROIC)	3.76%
Return on Capital Employed (ROCE)	6.05%
Revenue Per Employee	3.30B
Profits Per Employee	116.37M
Employee Count	808
Asset Turnover	0.82
Inventory Turnover	2.58

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.93% in the last 52 weeks. The beta is 0.57, so PT Suparma Tbk's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	-12.93%
50-Day Moving Average	267.24
200-Day Moving Average	293.49
Relative Strength Index (RSI)	38.86
Average Volume (20 Days)	274,120

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PT Suparma Tbk had revenue of IDR 2.71 trillion and earned 95.43 billion in profits. Earnings per share was 30.25.

Revenue	2.71T
Gross Profit	393.46B
Operating Income	175.57B
Pretax Income	120.65B
Net Income	95.43B
EBITDA	287.59B
EBIT	175.57B
Earnings Per Share (EPS)	30.25

Full Income Statement

Balance Sheet

The company has 153.92 billion in cash and 581.09 billion in debt, giving a net cash position of -427.16 billion or -135.43 per share.

Cash & Cash Equivalents	153.92B
Total Debt	581.09B
Net Cash	-427.16B
Net Cash Per Share	-135.43
Equity (Book Value)	2.40T
Book Value Per Share	760.24
Working Capital	905.09B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 656.18 billion and capital expenditures -36.31 billion, giving a free cash flow of 619.86 billion.

Operating Cash Flow	656.18B
Capital Expenditures	-36.31B
Free Cash Flow	619.86B
FCF Per Share	196.53

Full Cash Flow Statement

Margins

Gross margin is 14.53%, with operating and profit margins of 6.48% and 3.52%.

Gross Margin	14.53%
Operating Margin	6.48%
Pretax Margin	4.45%
Profit Margin	3.52%
EBITDA Margin	10.62%
EBIT Margin	6.48%
FCF Margin	22.88%

Dividends & Yields

This stock pays an annual dividend of 12.00, which amounts to a dividend yield of 4.69%.

Dividend Per Share	12.00
Dividend Yield	4.69%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	39.57%
Buyback Yield	n/a
Shareholder Yield	4.69%
Earnings Yield	11.82%
FCF Yield	76.77%

Dividend Details

Stock Splits

The last stock split was on June 15, 2022. It was a forward split with a ratio of 1.13.

Last Split Date	Jun 15, 2022
Split Type	Forward
Split Ratio	1.13

Scores

PT Suparma Tbk has an Altman Z-Score of 2.31. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.31
Piotroski F-Score	n/a